Follow us

AGuIX Preclinical data oncology – Archives

2021 – Archives Scientific Publications: AGuIX® Preclinical Data Oncology

Rapid evaluation of novel therapeutic strategies using a 3D collagen-based tissue-like model
Front. Bioeng. Biotechnol., 2021, 9, 53.
P. Maury, E. Porcel, A. Mau, et al.

View Article

Quantifying nanotherapeutic penetration using a hydrogel-based microsystem as a new 3D in vitro platform
Lab on a Chip, 2021, 21, 2495-2510.
S. Goodarzi, A. Prunet, F. Rossetti, et al.

View Article

3D Spatial Distribution of Nanoparticles in Mice Brain Metastases by X-ray Phase-Contrast Tomography
Frontiers in Oncology, 2021, 25, 554668.
E. Longo, L. Sancey, A. Cedola, et al.

View Article

Quantitative tissue pharmacokinetics and EPR effect of AGuIX® nanoparticles: a multimodal imaging study in an orthotopic glioblastoma rat model and healthy macaque
Adv Healthc Mater., 2021, 1, e2100656.
V.-L. Tran, F. Lux, N. Tournier, et al.

View Article

2020 – Archives Scientific Publications: AGuIX® Preclinical Data Oncology

Radiosensitization effect of AGuIX, a gadolinium-based nanoparticle, in nonsmall cell lung cancer
Applied Materials & Interfaces, 2020, 12, 56874-56885
Y. Du, H. Sun, F. Lux Y. Xie, L. Du, C. Xu, H. Zhang, N. He, J. Wang, Y. Liu, G. Leduc, T. Doussineau, K. Ji, Q. Wang, Z. Lin, Y. Wang, Q. Liu, O. Tillement

View Article

Enhanced MRI-guided radiotherapy with gadolinium-based nanoparticles: preclinical evaluation with an MRI-LINAC
Cancer Nanotechnology, 2020, 11, 1-14.
H. L. Byrne, G. Le Duc, F. Lux, O. Tillement, N. M. Holmes, A. James, U. Jelen, B. Dong, G. Liney, T. L. Roberts, Z. Kundic

View Article

Multiparametric investigation of non functionalized-AGuIX nanoparticles in 3D human airway epithelium models demonstrates preferential targeting of tumor cells
J. Nanobiotechnol., 2020, 18, 129.
L. Sancey, O. Sabido, Z. He, F. Rossetti, A. Guignandon, V. Bin, J. –L. Coll, M. Cottier, F. Lux, O. Tillement, S. Constant, C. Mas, D. Boudard

View Article

Gadolinium-based nanoparticles can overcome the radioresistance of head and neck squamous cell carcinoma through the induction of autophagy
J. Biomed. Nanotechnol., 2020, 16, 11-124.
S. Simonet, C. Rodriguez-Lafrasse, D. Beal, S. Gerbaud, C. Malesys, O. Tillement, F. Lux, H. Fayyad-Kazan, W. Rachidi, D. Ardail

View Article

2019 – Archives Scientific Publications: AGuIX® Preclinical Data Oncology

Ultrasmall theranostic gadolinium-based nanoparticles to improve high-grade rat glioma survival
J. Clin. Neurosci., 2019, 18, 31833.
S. Dufort, G. Appelboom, C. Verry, E. L. Barbier, F. Lux, E. Bräuer-Krisch, L. Sancey, S. D. Chang, M. Zhang, S. Roux, O. Tillement, G. Le Duc

View Article

Evaluation of the theranostic properties of gadolinium-based nanoparticles for head and neck cancer
Head Neck, 2019, 41, 403-410
R. Quatre, T. Jacquet, I. Atallah, O. Tillement, F. Lux, J. –L. Coll., S. Dufort, C. –A. Righini

View Article

2016 – Archives Scientific Publications: AGuIX® Preclinical Data Oncology

Key clinical beam parameters for nanoparticle-mediated radiation dose amplification
Scientific Report, 2016, 6, 34040.
A. Detappe, S. Kunjachan, P. Drané, S. Kotb, M. Myronakis, D. E. Biancur, T. Ireland, M. Wagar, F. Lux, O. Tillement, R. Berbeco

View Article

Effect of gadolinium-based nanoparticles on nuclear DNA damage and repair in glioblastoma tumor cells
J. Nanobiotechnology, 2016, 14, 63.
L. Stefancikova, S. Lacombe, D. Salado, E. Porcel, E. Pagacova, O. Tillement, F. Lux, D. Depes, S. Kozubek, M. Falk

View Article

Improving proton therapy by metal-containing nanoparticles : nanoscale insights
Int. J. Nanomedicine, 2016, 11, 1549-1556.
T. Schlathölter, P. Eustache, E. Porcel, D. Salado, L. Stefancikova, O. Tillement, F. Lux, P. Mowat, A. K. Biegun, M. –J. van Goethem, H. Remita, S. Lacombe

View Article

2015 – Archives Scientific Publications: AGuIX® Preclinical Data Oncology

Evaluation of a gadolinium-based nanoparticle (AGuIX) for contrast enhanced MRI of the liver in a rat model of hepatic colorectal cancer metastases at 9.4 tesla
Rofo., 2015, 187, 1108-1115.
P. Fries, D. Morr, A. Müller, F. Lux, O. Tillement, A. Massmann, R. Seidel, T. Schäfer, M. D. Mengel, G. Schneider, A. Bücker

View Article

Gadolinium nanoparticles and contrast agent as radiation sensitizers
Phys. Med. Biol., 2015, 60, 4449-4464.
F. Taupin, M. Flaender, R. Delorme, T. Brochard, J.F. Mayol, J. Arnaud, P. Perriat, L. Sancey, F. Lux, R. F. Barth, M. Carrière, J. L. Ravanat, H. Elleaume

View Article

Orotracheal administration of contrast agents : a new protocol for brain tumor targeting
NMR Biomed., 2015, 28, 738-746.
A. Bianchi, D. Moncelet, F. Lux, M. Plissonneau, S. Rizzitelli, E. J. Ribot, N. Tassali, V. Bouchaud, O. Tillement, P. Voisin, Y. Crémillieux

View Article

Nebulized gadolinium-based nanoparticles : a theranostic approach for lung tumor imaging and radiosensitization
Small, 2015, 11, 215-221.
S. Dufort, A. Bianchi, M. Henry, F. Lux, G. Le Duc, V. Josserand, C. Louis, P. Perriat, Y. Crémillieux, O. Tillement, J.-L. Coll

View Article

Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma
Nanomedicine:NBM, 2015, 11, 247-257.
I. Miladi, M. –T. Aloy, E. Armandy, P. Mowat, D. Kryza, N. Magné, O. Tillement, F. Lux, C. Billotey, M. Janier, C. Rodriguez-Lafrasse

View Article

2014 – Archives Scientific Publications: AGuIX® Preclinical Data Oncology

Cell localisation of gadolinium-based nanoparticles and related radiosensitizing efficacy in glioblastoma cells
Cancer Nanotechnology, 2014, 5, 6.
L. Stefancikova, E. Porcel, P. Eustache, S. Li, D. Salaso, S. Marco, J.-L. Guerquin-Kern, M. Réfrégiers, O. Tillement, F. Lux, S. Lacombe

View Article

Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
Cancer Nanotechnology, 2014, 5, 4.
G. Le Duc, S. Roux, A. Paruta-Tuarez, S. Dufort, E. Brauer, A. Marais, C. Truillet, L. Sancey, P. Perriat, F. Lux, O. Tillement

View Article

Gadolinium-based nanoparticles to improve the hadrontherapy performances
Nanomedicine:NBM, 2014, 10, 1601-1608.
E. Porcel, O. Tillement, F. Lux, P. Mowat, N. Usami, K. Kobayashi, Y. Furusawa, C. Le Sech, S. Li, S. Lacombe

View Article

Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents
PNAS, 2014, 111, 9247-9252.
A. Bianchi, S. Dufort, F. Lux, P.-Y. Fortin, N. Tassali, O. Tillement, J. –L. Coll, Y. Crémillieux

View Article

Radiation dose enhancement of gadolinium-based AGuIX nanoparticles on HeLa cells
Nanomedicine, 2014, 10, 1751-1755.
M. Luchette H. Korideck, M. Makrigiorgos, O. Tillement, R. Berbeco

View Article

2013 – Archives Scientific Publications: AGuIX® Preclinical Data Oncology

Biodistribution of ultrasmall gadolinium-based nanoparticles as theranostic agent : Application to brain tumors
J. Biomater. Appl., 2013, 28, 385-394.
I. Miladi, G. Le Duc, D. Kryza, A. Berniard, P. Mowat, S. Roux, J. Taleb, P. Bonazza, P. Perriat, F. Lux, O. Tillement, C. Billotey, M. Janier

View Article

Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles
Biomaterials, 2013, 34, 181-195.
W. Rima, L. Sancey, M. -T. Aloy, E. Armandy, G. B. Alcantara, T. Epicier, A. Malchère, L. Joly-Puttoz, P. Mowat, F. Lux, O. Tillement, B. Burdin, A. Rivoire, C. Boulé, I. Anselme-Bertrand, J. Pourchez, M. Cottier, S. Roux, C. Rodriguez-Lafrasse, P. Perriat

View Article

2011 – Archives Scientific Publications: AGuIX® Preclinical Data Oncology

Towards an image-guided microbeam radiation therapy using gadolinium-based nanoparticles
ACS Nano, 2011, 5, 9566-9574.
G. Le Duc, I. Miladi, C. Alric, P. Mowat, E. Bräuer-Krisch, A. Bouchet, E. Khalil, C. Billotey, M. Janier, F. Lux, P. Perriat, S. Roux, O. Tillement

View Article

In vitro radiosensitizing effects of ultrasmall gadolinium based particles on tumour cells
J. Nanosci. Nanotechnol., 2011, 11, 7833-7839.
P. Mowat, A. Mignot, W. Rima, F. Lux, O. Tillement, C. Roulin, M. Dutreix, D. Bechet, S. Huger, L. Humbert, M. Barberi-Heyob, M.T. Aloy, E. Armandy, C. Rodriguez-Lafrasse, G. Le Duc, S. Roux, P. Perriat

View Article